In 2025, hearing healthcare captured broad attention as research, clinical innovation, and real-world impact converged in compelling ways. This year’s most-read stories reflected deepening insights into tinnitus and hyperacusis, advancing evidence on hearing loss and cognitive health, and progress toward novel therapeutics — from cell-based approaches to synapse-targeted treatments. Alongside scientific and clinical milestones, developments in care delivery, workforce dynamics, and accessibility technology underscored how the field is evolving to meet diverse patient needs.
Below, we present the Top 10 Most Read news stories of 2025, highlighting the breakthroughs, debates, and innovations that resonated most with our community and helped shape the conversation in hearing health this year.
Top 10 Hearing News Stories of 2025
1) Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 in Meniere’s Disease
In December, the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to Sound Pharmaceuticals’ investigational oral drug SPI-1005 for the treatment of hearing loss associated with Ménière’s disease — the first such designation for any drug targeting this inner-ear disorder, which currently has no FDA-approved therapies. SPI-1005, an anti-inflammatory agent that has also met co-primary efficacy endpoints in a pivotal Phase 3 trial, is being developed for several neurotologic conditions including noise-induced hearing loss and ototoxicity, underscoring its potential as a novel therapeutic option.
2) Hearing Loss and Cognitive Decline: New Research Reinforces the Link and the Role of Early Intervention
New research from long-term and pilot studies reinforced the strong association between hearing loss and cognitive decline, showing that greater hearing impairment over decades was linked with worse cognitive outcomes and suggesting that early identification could be critical. The pilot Treating Auditory Impairment and Cognition Trial (TACT) study also indicated that structured hearing aid use may help preserve cognitive function in older adults with mild impairment, highlighting both the potential and the need for further study on interventions that support brain health.
3) Single Dose of AC102 Nearly Eliminates Tinnitus and Restores Auditory Synapses in Preclinical Study
Researchers reported that a single dose of the novel compound AC102 nearly eliminated tinnitus-like behavior in a preclinical acoustic trauma animal model while also restoring synaptic connections between inner ear sensory cells and the auditory nerve. With no currently approved drug treatments for tinnitus, these findings — published in the International Journal of Molecular Sciences — highlight the potential of AC102’s synapse-targeted approach as a promising step toward a new treatment for tinnitus.
4) Senators Warren, Paul, Grassley Reintroduce Medicare Audiology Access Improvement Act in U.S. Senate
In June, a bipartisan group of U.S. senators reintroduced the Medicare Audiology Access Improvement Act (MAAIA) to modernize Medicare by removing outdated barriers and allowing beneficiaries to access the full range of hearing and balance care provided by licensed audiologists. The legislation, backed by major hearing and aging organizations, aims to reclassify audiologists as practitioners and streamline reimbursement so seniors and people with disabilities can receive more timely, affordable audiologic services.
5) Sydney Opera House Introduces Auracast™, Transforming Hearing Accessibility in a World-First for a Cultural Institution
In March, the Sydney Opera House demonstrated Auracast™ broadcast audio through a collaboration between GN, Hearing Australia, and the National Acoustic Laboratories, enabling direct wireless audio streaming to compatible hearing aids and personal devices during performances and venue tours. The project highlighted how emerging wireless standards can expand accessible listening options in large public venues, offering users greater control over clarity and volume without relying on traditional assistive listening systems.
6) Vestibular Function Testing Aids in Differentiating Menière’s Disease from Vestibular Migraine, Study Finds
A new study from the Netherlands reported that vestibular function tests—particularly the video head impulse test (vHIT) and caloric testing—showed distinct patterns that can help clinicians differentiate between Ménière’s disease and vestibular migraine, two conditions with often overlapping symptoms. The findings suggest that objective vestibular assessments may play a more meaningful role in improving diagnostic confidence and guiding appropriate management for patients with complex dizziness presentations.
7) Up to 32% of Dementia Cases May Be Attributable to Hearing Loss, Study Finds
A large cohort study published in JAMA Otolaryngology–Head & Neck Surgery reported that nearly one in three dementia cases over an eight-year period could be attributed to objectively measured hearing loss, emphasizing the strength of the hearing-dementia connection. The findings highlight the potential public health impact of routine audiometric screening and greater access to hearing care as part of strategies to support cognitive health in aging populations.
8) UK Approves First Human Trial of Rinri’s Rincell-1 Cell Therapy for Hearing Loss
In August, Rinri Therapeutics announced the initiation of the first-in-human clinical trial evaluating its investigational cell therapy designed to regenerate auditory neurons and restore hearing function. The Phase 1 study represents a significant milestone in regenerative approaches to hearing loss, with early safety and feasibility data expected to inform future development and refinement of inner-ear biologic treatments.
8) Workplace Impact of Tinnitus and Hyperacusis Highlighted in New Research
A study published in the International Journal of Audiology found that more than half of patients with tinnitus or hyperacusis reported reduced work capacity, and that hyperacusis severity was a strong predictor of both reduced ability and work absence. The findings underscore how auditory symptoms themselves — independent of anxiety or depression — can impair occupational functioning and highlight the need for workplace awareness and supportive interventions.
9) New Study Finds 61% Reduced Dementia Risk Among Hearing Aid Users Under 70
Adults with hearing loss who began using hearing aids in their 60s had a significantly lower risk of developing dementia, suggesting that earlier intervention may help protect brain health decades later. Notably, the benefit was observed in participants under age 70, while no significant reduction in dementia risk was seen among those who initiated hearing aid use at older ages, highlighting the importance of timing in hearing intervention.
10) Lenire Tinnitus Device Shows Success in Real-World Clinical Study
A clinical study published in Nature Communications Medicine reported that treatment with the bimodal neuromodulation device Lenire was associated with statistically significant and sustained reductions in tinnitus symptom severity in a cohort of adults with chronic tinnitus. The findings add to the growing body of peer-reviewed research examining non-pharmacologic, device-based approaches for tinnitus management.
Looking Ahead…
As 2025 comes to a close, these most-read stories reflect a field increasingly grounded in evidence, precision, and long-term impact. This year’s coverage highlighted continued momentum in inner-ear therapeutics, growing clarity around the links between hearing loss, tinnitus, and broader health outcomes, and a steady shift toward earlier, more proactive intervention across the lifespan.
At the same time, developments in policy, diagnostic science, and accessibility technology reflected a broader shift toward earlier intervention, improved diagnostic clarity, and more inclusive listening environments.
As the field looks ahead to 2026, hearing healthcare appears increasingly focused on translating emerging evidence and therapeutic innovation into clinically meaningful, real-world applications that support long-term health and quality of life.
